Ethyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate-d9 is an intermediate in the synthesis of Febuxostat-d9 (F229002). Febuxostat-d9 is the labelled analogue of Febuxostat (F229000). Febuxostat is an Xanthine oxidase/xanthine dehydrogenase inhibitor, used for treatment of hyperuricemia and chronic gout.
